Philadelphia, United States
NeuroFlow, founded in 2017, is a pioneering digital health company based in the United States, working to bridge the gap in behavioral health access and engagement. With a focus on Digital Health, Health Care, Health and Wellness, and Sports, NeuroFlow is committed to enhancing healthcare outcomes.
The company's platform is designed to support risk-bearing healthcare organizations by offering real-time data collection and risk stratification that uncovers hidden behavioral health needs. This cutting-edge technology provides actionable insights, promoting a financially sustainable approach to managing complex populations.
Their innovative solution has captured the attention of investors, with the most recent undisclosed investment from Concord Health Partners on 01 September 2023. As an externally evaluated company, NeuroFlow's commitment to whole-person care positions it as a key player in proactively addressing the systemic challenges of today's healthcare system.
